Navigation Links
Genta Initiates First Clinical Trial with New Oral Drug (G4544) to Treat Bone Disease
Date:9/17/2007

l studies with G4544 will be to establish its bioequivalence with the intravenous product, potentially enabling rapid regulatory approval of the oral formulation. Genta holds or has exclusively licensed the intellectual property related to G4544.

About Genta

Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. The Company's research platform is anchored by two major programs that center on oligonucleotides (RNA- and DNA- based medicines) and small molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead compound from its oligonucleotide program. The leading drug in Genta's small molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the U.S. for treatment of symptomatic patients with cancer related hypercalcemia that is resistant to hydration. Genta is partnered with IDIS (http://www.idispharma.com) on a program whereby both Ganite(R) and Genasense(R) are available on a "named- patient" basis in countries outside the United States. For more information about Genta, please visit our website at: http://www.genta.com.

Safe Harbor

This press release may contain forward-looking statements with respect to business conducted by Genta Incorporated. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the future. Forward- looking statements include, without limitation, statements about:

-- the Company's ability to obtain necessary regulatory approval for

Genasense(R) from the U.S. Food and Drug Administration ("FDA") or

European Medicines Agency ("EMEA");

-- the safety and efficacy of the Company's products or produc
'/>"/>

SOURCE Genta Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Genta Announces Results of Phase 1 Study Using Genasense Administered by Intermittent Subcutaneous Injection
2. Genta Incorporated to Present Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
3. Malvern initiates European user group meetings for chemical imaging
4. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
5. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
6. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
7. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
8. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
9. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
10. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
11. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Jan. 23, 2015  Northwest Biotherapeutics, Inc. (NASDAQ: NWBO ... therapies for operable and inoperable solid tumor cancers, announced today ... 7 th Annual Phacilitate Immunotherapy Forum in ... Phacilitate will take place on January 26 at 10:30 a.m. ...
(Date:1/23/2015)... 23, 2015 /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ) is ... Advaxis, Inc. ("Advaxis" or the "Company") (NASDAQ: ... fiduciary duties to shareholders. On January 21, ... reporting that Advaxis had misrepresented the clinical data for ...
(Date:1/23/2015)... , Jan. 23, 2015  iMD Companies, Inc. (ICBU) has repositioned ... market share and grab a foothold in the hydroponic, hemp ... capabilities and a presence in the sector, and recently partnering ... growth of hemp and medical marijuana, iMD is committing to ...
Breaking Medicine Technology:NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2
... Jan. 25, 2011 / PRNewswire/ -- ... through the Pharmacy Technician Certification Board (PTCB), a pioneer ... have earned the PTCB Certified Pharmacy Technician (CPhT) credential ... the Pharmacy Technician Certification Exam (PTCE) in 2010 alone. ...
... Jan. 25, 2011 Reportlinker.com announces that a new ... The Drug Delivery Device Market Outlook ... Drug delivery device manufacturers are experiencing ... their buying power and reducing the contract prices for ...
Cached Medicine Technology:Record Number of Pharmacy Technicians Seek Certification Through PTCB 2Record Number of Pharmacy Technicians Seek Certification Through PTCB 3Reportlinker Adds The Drug Delivery Device Market Outlook to 2015 2Reportlinker Adds The Drug Delivery Device Market Outlook to 2015 3
(Date:1/22/2015)... TX (PRWEB) January 22, 2015 A ... issue of experience and person-centeredness in the long-term care ... towards action across the continuum. The paper, “The Power ... Continuum,” engages perspectives and practices of the patient, resident ...
(Date:1/22/2015)... January 22, 2015 Carinsurancesavings.biz has released a ... death and dismemberment insurance . , Purchasing an accidental ... be very advantageous. This type of rider provides benefits if ... can be considered a lesser form of life insurance. ...
(Date:1/22/2015)... 23, 2015 Recently, Weddingshe.com has added many ... has announced its highest annual revenues in the past three ... popular glamorous wedding dresses. , According to the sales manager ... dress promotions for them in 2015. This point can be ...
(Date:1/22/2015)... EBSCO Information Services (EBSCO) and the ... an effort to further promote visibility and adoption of the ... made AMA journals available via its subscription services, EBSCO will ... , Long known as both a subscription agency ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Lower-Auto-Insurance.com has released a ... kit in a car for reducing the costs of an ... will also be able to get lower prices for their vehicle ... an important role in determining policy costs. Because of this, ...
Breaking Medicine News(10 mins):Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2
... PARIS and MARSEILLE, France, January 11 ... signing of a,scientific collaboration agreement in the breast cancer domain. ... Ipsogen,s,MapQuant Dx Grade Genomic, HER2 and HR tests will be ... patients treated at the Institut,Curie. The aim of this collaboration ...
... , CHICAGO, Jan. 11 ... Stimulus Program , making it safe and easy for physicians ... qualify for significant federal incentives. , (Logo: http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO ) ... a guarantee that the Allscripts EHR they select will meet ...
... , , ... MDRX ) announced today that Renaissance Medical Management Company (RMMC) ... Practice Management solution to automate and connect clinical and ... medicine physicians. The new service offering from RMMC builds upon the ...
... ... months and shared his story on ABC,s Good Morning America on January 8, 2010 , ... New York, NY (PRWEB) January 11, 2010 -- ... ago, kicked off 2010 with an appearance on ABC,s Good Morning America last Friday, feeling and ...
... ... simply spelling correctly the Hebrew word Sun ( SheMeSh éÞé) in English Letters as ... ... years of research, Joseph Lanyadoo concludes that language was neither invented by humans ...
... , CHICAGO, Jan. 10 Allscripts-Misys Healthcare ... for the three and six months ended November 30, 2009. ... Highlights: , Total revenue of $169.3 million; non-GAAP ... cents; non-GAAP earnings per share of $0.16 cents Net income ...
Cached Medicine News:Health News:The Institut Curie and Ipsogen Sign a Scientific Collaboration Agreement Relating to the Genomic Grade, a Molecular Diagnostic Tool for Breast Cancer 2Health News:The Institut Curie and Ipsogen Sign a Scientific Collaboration Agreement Relating to the Genomic Grade, a Molecular Diagnostic Tool for Breast Cancer 3Health News:Allscripts Announces Rapid Implementation, 'Meaningful Use' Guarantee, and Financing Programs for Electronic Health Records 2Health News:Allscripts Announces Rapid Implementation, 'Meaningful Use' Guarantee, and Financing Programs for Electronic Health Records 3Health News:Allscripts Announces Rapid Implementation, 'Meaningful Use' Guarantee, and Financing Programs for Electronic Health Records 4Health News:Allscripts Announces Rapid Implementation, 'Meaningful Use' Guarantee, and Financing Programs for Electronic Health Records 5Health News:Allscripts Announces Rapid Implementation, 'Meaningful Use' Guarantee, and Financing Programs for Electronic Health Records 6Health News:Renaissance Medical Management Company Selects Allscripts Electronic Health Record and Practice Management 2Health News:Renaissance Medical Management Company Selects Allscripts Electronic Health Record and Practice Management 3Health News:Renaissance Medical Management Company Selects Allscripts Electronic Health Record and Practice Management 4Health News:Renaissance Medical Management Company Selects Allscripts Electronic Health Record and Practice Management 5Health News:Renaissance Medical Management Company Selects Allscripts Electronic Health Record and Practice Management 6Health News:Renaissance Medical Management Company Selects Allscripts Electronic Health Record and Practice Management 7Health News:Happy New Year for Marty: Arizona Man Drops 164 Pounds on Dr. Siegal's COOKIE DIET and Appears on ABC's Good Morning America 2Health News:Happy New Year for Marty: Arizona Man Drops 164 Pounds on Dr. Siegal's COOKIE DIET and Appears on ABC's Good Morning America 3Health News:New 20 Year Research Confirms the Biblical Assertion that Hebrew is the Original Proto-Language Confounded By the Gods 2Health News:New 20 Year Research Confirms the Biblical Assertion that Hebrew is the Original Proto-Language Confounded By the Gods 3Health News:New 20 Year Research Confirms the Biblical Assertion that Hebrew is the Original Proto-Language Confounded By the Gods 4Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 2Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 3Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 4Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 5Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 6Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 7Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 8Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 9Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 10Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 11Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 12Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 13Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 14Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 15Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 16Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 17Health News:Allscripts Reports Fiscal 2010 Second Quarter Results 18
The Guidant Fineline leads are bipolar endocardial and designed for permanent implantation with pulse generators for cardiac pacing....
... The Guidant Flextend lead ... pace/sense lead with an ... extendable/retractable helix design offers ... for permanent implantation in ...
The RU is a low profile implantable bipolar tined permanent pacing lead for stimulation of either the atrium (J model) or the ventricle (straight model)....
... The Vitatron Crystalline lead ... specifically designed for optimal sensing ... reducing the sensing of far-field ... Crystalline leads allow a higher ...
Medicine Products: